Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-25T01:44:59.730Z Has data issue: false hasContentIssue false
  • English
  • Français

Introducing Innovation into Practice: Technical and Ethical Analyses of PGD and ICSI Technologies

Published online by Cambridge University Press:  01 January 2021

Gladys B. White  and
Michael E. McClure
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Introduction
Information
Journal of Law, Medicine & Ethics , Volume 26 , Issue 1 , Spring 1998 , pp. 5 - 6
Copyright
Copyright © American Society of Law, Medicine and Ethics 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

See generally U.S. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology, and RESOLVE, 1995 Assisted Reproductive Technology Success Rates, National Summary and Fertility Clinic Reports (Washington, D.C.: U.S. Department of Health and Human Services, Vols. 1–3, Dec. 1997) [henceforth Assisted Reproductive Technology].Google Scholar
See generally Tasca, R.J. McClure, M.E., “The Emerging Technology and Application of Preimplantation Genetic Diagnosis,” Journal of Law, Medicine & Ethics, 26 (1998): 7–16.CrossRefGoogle Scholar
See Assisted Reproductive Technology, supra note 1, at 11.Google Scholar
See Cummins, J., Reproduction, “ICSI May Foster Birth Defects,” Journal of NIH Research, 9, no. 2 (1997): 34, 36, 38, 40; and Tournaye, H. Van Steirteghem, A., Reproduction, “ICSI Concerns Do Not Outweigh Its Benefits,” Journal of NIH Research, 9, no. 2 (1997): 35, 37, 39, 40. Compare to Van Steirteghem, A., “Ethical Considerations of Intracytoplasmic Sperm Injection,” in Shenfield, F. Sureau, C., eds., Ethical Dilemmas in Assisted Reproduction (London: Parthenon Press, Studies in Profertility Series, Vol. 7, 1997): 51–56.Google Scholar
See Bonduelle, M., “Mental Development of 201 ICSI Children at 2 Years of Age,” Lancet, 351 (1998): 1553; and Bowen, J.R., “Medical and Developmental Outcome at 1 Year from Children Conceived by Intracytoplasmic Sperm Injection,” Lancet, 351 (1998): 1529–34.Google Scholar
See Milliez, J. Sureau, C., “Pre-Implantation Diagnosis and the Eugenics Debate: Our Responsibility to Future Generations,” in Shenfield, Sureau, , supra note 4, at 57–66.Google Scholar
New York State Task Force on Life and the Law, Assisted Reproductive Technologies: Analysis and Recommendations for Public Policy (New York: New York State Task Force on Life and the Law, Apr. 1998): At xiv.Google Scholar
See Steirteghem, Van, supra note 4.Google Scholar
See generally Schatten, G., “Cell and Molecular Biological Challenges of ICSI: ART Before Science?,” Journal of Law, Medicine & Ethics, 26 (1998): 29–37.Google Scholar
See generally Botkin, J.R., “Ethical Issues and Practical Problems in Preimplantation Genetic Diagnosis,” Journal of Law, Medicine & Ethics, 26 (1998): 17–28.Google Scholar